omniture
logo
Search
LUNIT INC
Media Room

Photo News

rss
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

2024-11-18 22:00 1272
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network

Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network

2024-11-13 22:00 1497
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024

Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024

2024-11-08 22:00 2568
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance

Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance

2024-10-23 21:00 1759
Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024

Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024

2024-09-10 21:00 1446
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

2024-09-09 21:00 1335
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR

Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR

2024-09-03 21:00 1461
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study

2024-08-06 21:00 1852
Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

2024-07-22 21:00 2266
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

2024-05-24 22:07 5475
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

2024-05-22 21:00 2062
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite

2024-05-20 21:00 2009
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

2024-04-08 21:00 1840
Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

2024-04-01 21:00 1993
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

2024-03-26 21:00 1227
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

2024-03-18 21:00 1837
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

2024-03-14 21:00 1892
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

2024-02-28 22:03 1386
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

2024-02-16 22:03 5194
Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology

2024-01-17 22:15 1863
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

2024-01-16 22:04 1987
1234